Home LiteratureArticle Details
PMID: 10203736 Published · ppublish English Journal Article Review

The molecular pathogenesis of endotoxic shock and organ failure.

Molecular medicine today ·Vol. 5 ·No. 3 ·1999-03-00 ·Pages 123-32

Karima R, Matsumoto S, Higashi H, Matsushima K

Abstract

Sepsis is still associated with a high mortality rate. Septic shock and sequential multiple organ failure have a strong correlation with poor outcome. Lipopolysaccharide (LPS) plays a pivotal role in the initiation of host responses to Gram-negative infection. A number of mediators, such as cytokines, nitric oxide and eicosanoids, are responsible for most of the manifestations caused by LPS, and circulatory failure, leukocyte-induced tissue injury and coagulation disorder appear to be critical determinants in the development of sequential organ failure. Although several anti-LPS or anti-cytokine clinical trials have been attempted, none of them has so far been successful.

MeSH Terms
Gram-Negative Bacterial Infections/physiopathology Humans Inflammation Mediators/immunology,metabolism Lipopolysaccharides/immunology,metabolism Multiple Organ Failure/genetics,physiopathology,therapy Shock, Septic/genetics,physiopathology,therapy Signal Transduction
Chemicals
Inflammation Mediators Lipopolysaccharides
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Karima R
Dept of Molecular Preventive Medicine, Faculty of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyou-ku, Tokyo, 113-0033, Japan.
Matsumoto S
Higashi H
Matsushima K
Article Info
Journal
Molecular medicine today
Abbr.
Mol Med Today
ISSN
1357-4310
Published
1999-03-00
Pages
123-32
Language
English
Region
England
NLM ID
9508560
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com